247 related articles for article (PubMed ID: 33513862)
1. Safety, Immunogenicity, and Protective Efficacy of a Chimeric A/B Live Attenuated Influenza Vaccine in a Mouse Model.
Stepanova E; Krutikova E; Wong PF; Matyushenko V; Bazhenova E; Isakova-Sivak I; Rudenko L
Microorganisms; 2021 Jan; 9(2):. PubMed ID: 33513862
[TBL] [Abstract][Full Text] [Related]
2. Safety, Immunogenicity, and Protective Efficacy of an H5N1 Chimeric Cold-Adapted Attenuated Virus Vaccine in a Mouse Model.
Sun W; Wang Z; Sun Y; Li D; Zhu M; Zhao M; Wang Y; Xu J; Kong Y; Li Y; Feng N; Wang T; Zhao Y; Yang S; Gao Y; Xia X
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960689
[TBL] [Abstract][Full Text] [Related]
3. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.
Liu WC; Nachbagauer R; Stadlbauer D; Solórzano A; Berlanda-Scorza F; García-Sastre A; Palese P; Krammer F; Albrecht RA
Front Immunol; 2019; 10():756. PubMed ID: 31105689
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.
Heldens J; Hulskotte E; Voeten T; Breedveld B; Verweij P; van Duijnhoven W; Rudenko L; van Damme P; van den Bosch H
Vaccine; 2014 Sep; 32(39):5118-24. PubMed ID: 24858566
[TBL] [Abstract][Full Text] [Related]
5. Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses.
Matyushenko V; Kotomina T; Kudryavtsev I; Mezhenskaya D; Prokopenko P; Matushkina A; Sivak K; Muzhikyan A; Rudenko L; Isakova-Sivak I
Antiviral Res; 2020 Oct; 182():104864. PubMed ID: 32585323
[TBL] [Abstract][Full Text] [Related]
6. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and efficacy comparison of MDCK cell-based and egg-based live attenuated influenza vaccines of H5 and H7 subtypes in ferrets.
Yeolekar LR; Guilfoyle K; Ganguly M; Tyagi P; Stittelaar KJ; van Amerongen G; Dhere RM; BerlandaScorza F; Mahmood K
Vaccine; 2020 Sep; 38(40):6280-6290. PubMed ID: 32741671
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Live Attenuated Influenza Vaccine Viruses Carrying Conserved T-cell Epitopes of Human Adenoviruses Induce Functional Cytotoxic T-Cell Responses and Protect Mice against Both Infections.
Isakova-Sivak I; Matyushenko V; Stepanova E; Matushkina A; Kotomina T; Mezhenskaya D; Prokopenko P; Kudryavtsev I; Kopeykin P; Sivak K; Rudenko L
Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32344618
[TBL] [Abstract][Full Text] [Related]
9. Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge.
Isakova-Sivak I; Matyushenko V; Kotomina T; Kiseleva I; Krutikova E; Donina S; Rekstin A; Larionova N; Mezhenskaya D; Sivak K; Muzhikyan A; Katelnikova A; Rudenko L
Vaccines (Basel); 2019 Jul; 7(3):. PubMed ID: 31288422
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of influenza A and B cold-adapted reassortant virus reproduction in trivalent live influenza vaccines.
Landgraf G; Desheva YA; Rudenko LG
Virus Res; 2021 Jul; 300():198396. PubMed ID: 33744337
[TBL] [Abstract][Full Text] [Related]
11. Development of an Alternative Modified Live Influenza B Virus Vaccine.
Santos JJS; Finch C; Sutton T; Obadan A; Aguirre I; Wan Z; Lopez D; Geiger G; Gonzalez-Reiche AS; Ferreri L; Perez DR
J Virol; 2017 Jun; 91(12):. PubMed ID: 28381580
[TBL] [Abstract][Full Text] [Related]
12. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
13. Heterosubtypic protection against avian influenza virus by live attenuated and chimeric norovirus P-particle-M2e vaccines in chickens.
Ghorbani A; Ngunjiri JM; Xia M; Elaish M; Jang H; Mahesh KC; Abundo MC; Jiang X; Lee CW
Vaccine; 2019 Feb; 37(10):1356-1364. PubMed ID: 30691981
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains.
Yeolekar LR; Ganguly M; Tyagi P; Ingle NB; Stittelaar KJ; Waal L; Scorza FB; Mahmood K; Dhere RM
Vaccine; 2018 Nov; 36(46):6944-6952. PubMed ID: 30322745
[TBL] [Abstract][Full Text] [Related]
15. Generation and Characterization of Universal Live-Attenuated Influenza Vaccine Candidates Containing Multiple M2e Epitopes.
Kotomina T; Isakova-Sivak I; Kim KH; Park BR; Jung YJ; Lee Y; Mezhenskaya D; Matyushenko V; Kang SM; Rudenko L
Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33153089
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.
Block SL; Yi T; Sheldon E; Dubovsky F; Falloon J
Vaccine; 2011 Nov; 29(50):9391-7. PubMed ID: 21983154
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein.
Rekstin A; Isakova-Sivak I; Petukhova G; Korenkov D; Losev I; Smolonogina T; Tretiak T; Donina S; Shcherbik S; Bousse T; Rudenko L
Biomed Res Int; 2017; 2017():9359276. PubMed ID: 28210631
[TBL] [Abstract][Full Text] [Related]
18. Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice.
Moser MJ; Hatta Y; Gabaglia C; Sanchez A; Dias P; Sarawar S; Kawaoka Y; Hatta M; Neumann G; Bilsel P
Vaccine; 2019 Jul; 37(32):4533-4542. PubMed ID: 31280945
[TBL] [Abstract][Full Text] [Related]
19. Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains.
Jang YH; Lee EY; Byun YH; Jung EJ; Lee YJ; Lee YH; Lee KH; Lee J; Seong BL
Vaccine; 2014 Jan; 32(5):535-43. PubMed ID: 24342248
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and Protective Efficacy of Seasonal Human Live Attenuated Cold-Adapted Influenza Virus Vaccine in Pigs.
Holzer B; Morgan SB; Martini V; Sharma R; Clark B; Chiu C; Salguero FJ; Tchilian E
Front Immunol; 2019; 10():2625. PubMed ID: 31787986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
